| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |